Clinical Trial Update: Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 clinical trial evaluating the effectiveness and safety of CyberKnife treatment in patients with hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Liver Neoplasms | Phase 2 | Status: UNKNOWN